BIOMAT Database Logo BIOMAT Database Logo

Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis. 2001

F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Department of Clinical Chemistry, University Hospital Virgen de la Arrixaca, Murcia, Spain. fcanizares@hvax.insalud.es

The role of circulating tumor markers in providing prognostic information has not been widely studied. In the current study, serum levels of the carbohydrate antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) were determined preoperatively in 364 breast cancer patients with no clinical signs of metastasis. The prognostic relevance of these markers for recurrence (175/364) and death of disease (104/175) was determined by Cox multivariate analysis, including the comparison with classical prognostic factors. High levels of both tumor markers were associated with aneuploid tumors with high S-phase fraction and high ornithine decarboxylase activity. CA 15-3 was highly associated with the number of positive lymph nodes and peritumoral lymphatic or blood vessel invasion. No significant associations were found between CEA or CA 15-3 levels and histologic grade, necrosis and steroid receptor status. In univariate analysis, preoperative values, using optimum cutoff values of CA 15-3 (40 U/ml) and CEA (6 ng/ml), were statistically significant for relapse-free survival and overall survival. In multivariate analysis, only node status, DNA ploidy and ornithine decarboxylase activity were independent predictors for relapse-free survival; the estrogen receptor status was a predictor of overall survival. In node-negative patients, ornithine decarboxylase activity was the only factor selected for relapse-free survival. In node-positive patients, the number of lymph nodes and DNA ploidy were the only variables selected for relapse-free survival or overall survival. Estrogen receptor and ornithine decarboxylase activity were excluded for relapse-free survival, but were significant prognostic factors for overall survival.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009955 Ornithine Decarboxylase A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. Ornithine Carboxy-lyase,Carboxy-lyase, Ornithine,Decarboxylase, Ornithine,Ornithine Carboxy lyase
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast

Related Publications

F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
January 1999, Anticancer research,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer.
April 2002, British journal of cancer,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
[CA 15-3 and CEA markers - prognostic factors in breast cancer].
January 2001, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.
January 1997, Anticancer research,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes.
April 2008, Annals of oncology : official journal of the European Society for Medical Oncology,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.
May 2013, Annals of oncology : official journal of the European Society for Medical Oncology,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.
October 2008, International journal of clinical oncology,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Pretreatment values of serum CA 15-3 antigen related to prognostic factors in breast cancer patients.
January 1996, Neoplasma,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
Relationship between preoperative serum CA 15-3 and CEA levels and clinicopathological parameters in breast cancer.
January 2014, Asian Pacific journal of cancer prevention : APJCP,
F Cañizares, and J Sola, and M Pérez, and I Tovar, and M De Las Heras, and J Salinas, and R Peñafiel, and P Martínez
CEA and CA 15-3 in primary and recurrent breast cancer.
January 1990, World journal of surgery,
Copied contents to your clipboard!